ABACUS LIFE, INC., ISSUER AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, TRUSTEE SENIOR DEBT SECURITIES INDENTURE Dated as of [ ] [ ], 2023Indenture • September 29th, 2023 • Abacus Life, Inc. • Investment advice • New York
Contract Type FiledSeptember 29th, 2023 Company Industry JurisdictionINDENTURE, dated as of [ ] [ ], 2023, between ABACUS LIFE, INC., a corporation duly incorporated and existing under the laws of the State of Delaware (the “Company”), having its principal office at 2101 Park Center Drive, Suite 170, Orlando, Florida 32835 and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association, as Trustee (the “Trustee”).
FIRST SUPPLEMENTAL INDENTURE between ABACUS LIFE, INC. and Dated as of [ ] [ ], 2023First Supplemental Indenture • September 29th, 2023 • Abacus Life, Inc. • Investment advice
Contract Type FiledSeptember 29th, 2023 Company IndustryTHIS FIRST SUPPLEMENTAL INDENTURE (this “First Supplemental Indenture”), dated as of [ ] [ ], 2023, is between Abacus Life, Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). Except as otherwise set forth herein, all capitalized terms used herein shall have the meaning set forth in the Base Indenture (as defined below).
ABACUS LIFE, INC. [●]% Fixed Rate Senior Notes due 2028 UNDERWRITING AGREEMENTUnderwriting Agreement • September 29th, 2023 • Abacus Life, Inc. • Investment advice • New York
Contract Type FiledSeptember 29th, 2023 Company Industry JurisdictionAbacus Life, Inc., a Delaware corporation (the “Company”), confirms its agreements with Piper Sandler & Co. (“Piper Sandler”) and each of the other underwriters named in Exhibit A hereto (each, an “Underwriter,” and collectively, the “Underwriters,” which term shall also include any underwriter substituted as provided in Section 7 hereof), for whom Piper Sandler is acting as the representative (in such capacity, the “Representative”), (i) with respect to the issuance and sale by the Company of $[●] aggregate principal amount (the “Initial Securities”) of the Company’s [●]% Fixed Rate Senior Notes due 2028 (the “Notes”), and the purchase by the Underwriters, acting severally and not jointly, of the aggregate principal amount of Initial Securities set forth opposite their respective names in Exhibit A hereto, and (ii) with respect to the grant by the Company to the Underwriters of the option described in Section 2(b) hereof to purchase all or any part of $[●] aggregate principal amount o